Upcoming Financial Results Release for Apyx Medical Corporation
Apyx Medical Corporation (NASDAQ: APYX) is making headlines with its announcement regarding the fourth quarter and fiscal year 2024 financial results, set to be revealed before the market opens on Thursday. This significant event, taking place on March 13, signifies not just a routine financial update, but a crucial moment for stakeholders involved in the company.
Conference Call Details
On the same day as the financial report launch, Apyx Medical will host a conference call at 8:30 a.m. Eastern Time. This call will provide management with an opportunity to discuss the financial outcomes, answer questions, and clarify expectations for the upcoming periods.
Those interested in joining the call can connect by dialing 877-407-9039 for domestic calls or 201-689-8470 for international participants. Don’t forget to mention the access code: 13751519, and inquire about the Apyx Medical Corporation Call. It's set to be an insightful session, offering clarity on the company’s performance and future directions.
Webcast Availability
For those who prefer digital access, a live webcast of the call will be available. Interested parties can follow the webcast link provided by the company and also find the archived version later for reference. This flexibility allows stakeholders who may not have access to the phone system an avenue to stay informed about Apyx Medical’s financial results.
About Apyx Medical Corporation
Apyx Medical Corporation stands out as an advanced energy technology company dedicated to improving lives through innovative solutions. They are best known for their patented helium plasma devices marketed under the brand Renuvion. These groundbreaking products serve both the cosmetic surgery field and hospital surgical markets, emphasizing Apyx’s commitment to merging technology with medical expertise.
The Renuvion and J-Plasma technologies are particularly noteworthy, providing surgeons with unparalleled control over tissue heat application—helping achieve desired surgical results. With strong backing from over 90 clinical documents, Apyx Medical’s innovations showcase the potential of advanced medical device technology.
Investor Relations Contact
For inquiries related to these financial results or to gain insights into company strategies and products, Jeremy Feffer, the Managing Director at LifeSci Advisors, is available for contact. For further assistance, investors can reach him directly at 212-915-2568 or via email.
The commitment to quality and innovation is not only central to Apyx Medical's operations but also extends through collaborations with other medical device manufacturers, showcasing the depth of expertise the company possesses. Those keen on learning more can visit their official website, where comprehensive information about their offerings is accessible.
Frequently Asked Questions
1. When will Apyx Medical Corporation release its financial results?
The company will release its financial results for the fourth quarter and fiscal year 2024 on March 13.
2. What time is the conference call scheduled?
The conference call is scheduled for 8:30 a.m. Eastern Time on the same day as the financial results release.
3. How can I participate in the conference call?
To participate, call 877-407-9039 for domestic or 201-689-8470 for international calls, and use the access code 13751519.
4. Where can I find the webcast of the conference call?
A live webcast will be available through a link provided by the company and can be accessed later in an archived format.
5. How can I contact Apyx Medical for more information?
Jeremy Feffer, Managing Director at LifeSci Advisors, can be contacted for investor relations inquiries. He can be reached at 212-915-2568 or via email.
